MGNX
MACROGENICS INC
Health Care·Biotechnology·UNITED STATES
$4.40
MCap —
as of 2026-09-04
Total
C2w
Fund
D2w
Quant
A10w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.90
Sentiment 11.4%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$4.40
Adaptive Mean
$4.30
+0.10 vs mean
Adaptive σ
0.06
MIDOS BB
$4.18 – $4.41
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
-0.37
ROE
-225.8%
Z -1.53
Rev Gr
378.0%
Z +0.18
EPS Gr
—
Z -0.12
OPM Gr
162.1%
Z +0.26
FCF Yld
-24.8%
Z -1.76
EPS Surp
3.4%
Z -0.10
EPS 3mo Δ
-147.1%
Z +0.51
Fwd P/E
-3.00
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
4.84
Q6M
8.98
Q12M
6.92
MA 30/100
1.006
Bullish (MA30 > MA100)
α (Jensen)
0.4953
β (12M)
0.97
σ (12M)
0.870
Divergence — Fundamentals vs Momentum
Z Percentile
12%
Q Percentile
89%
Divergence
-76.3
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
118.3
RS Pctl
98%
RS Decile
D10
Persistence
2w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.